Combined diode laser cyclophotocoagulation and intravitreal bevacizumab (Avastin) in neovascular glaucoma
暂无分享,去创建一个
[1] Y. Tano,et al. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. , 2008, Ophthalmology.
[2] W. Tasman,et al. COMBINATION INTRAVITREAL BEVACIZUMAB/PANRETINAL PHOTOCOAGULATION VERSUS PANRETINAL PHOTOCOAGULATION ALONE IN THE TREATMENT OF NEOVASCULAR GLAUCOMA , 2008, Retina.
[3] A. Metheetrairut,et al. Surgical outcome of intravitreal bevacizumab and filtration surgery in neovascular glaucoma , 2008, Advances in therapy.
[4] S. Garg,et al. Role of intravitreal bevacizumab in neovascular glaucoma. , 2007, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[5] S. Yazdani,et al. Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma. , 2007, Journal of glaucoma.
[6] J. Grigg,et al. Bevacizumab (Avastin) for the treatment of neovascular glaucoma , 2007, Clinical & experimental ophthalmology.
[7] M. Iliev,et al. Long-term outcome of trans-scleral diode laser cyclophotocoagulation in refractory glaucoma , 2007, British Journal of Ophthalmology.
[8] S. Mohammadi,et al. Pars plana Ahmed valve implant and vitrectomy in the management of neovascular glaucoma. , 2006, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.
[9] M. Nagpal,et al. The use of intravitreal bevacizumab in neovascular glaucoma: a case report. , 2007, Bulletin de la Societe belge d'ophtalmologie.
[10] S. Wolf,et al. Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma. , 2006, American journal of ophthalmology.
[11] Michael A. Albert,et al. Regression of neovascular iris vessels by intravitreal injection of bevacizumab. , 2006, Retina.
[12] I. Scott,et al. Short-term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucoma. , 2006, Acta ophthalmologica Scandinavica.
[13] F. Davidorf,et al. Rapid improvement of rubeosis iridis from a single bevacizumab (Avastin) injection. , 2006, Retina.
[14] J. Diamond,et al. A two centre study of the dose-response relation for transscleral diode laser cyclophotocoagulation in refractory glaucoma , 2003, The British journal of ophthalmology.
[15] J. Sivak-Callcott,et al. Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma. , 2001, Ophthalmology.
[16] K. Martin,et al. Cyclodiode laser therapy for painful, blind glaucomatous eyes , 2001, The British journal of ophthalmology.
[17] M. Walland. Diode laser cyclophotocoagulation: longer term follow up of a standardized treatment protocol , 2000, Clinical & experimental ophthalmology.
[18] K. Chalam,et al. Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. , 1998, Ophthalmology.
[19] Joan W. Miller,et al. Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate. , 1996, Archives of ophthalmology.
[20] E S Gragoudas,et al. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. , 1996, Archives of ophthalmology.
[21] P. Khaw,et al. Combined transscleral diode laser cyclophotocoagulation and transscleral retinal photocoagulation for refractory neovascular glaucoma. , 1996, Retina.
[22] G. Brown,et al. Efficacy of panretinal photocoagulation in preventing neovascular glaucoma following ischemic central retinal vein obstruction. , 1982, Ophthalmology.
[23] R. Smith. Rubeotic glaucoma. , 1981, British Journal of Ophthalmology.
[24] W. Tasman,et al. Effects of argon laser photocoagulation on rubeosis iridis and angle neovascularization. , 1980, Ophthalmology.
[25] W. M. Grant,et al. Effects of panretinal photocoagulation on rubeosis iridis, angle neovascularization, and neovascular glaucoma. , 1978, American journal of ophthalmology.